Person:
ÖZMEN, ÖZGE

Loading...
Profile Picture
Status
Kurumdan Ayrılmıştır
Organizational Units
Job Title
Last Name
ÖZMEN
First Name
ÖZGE
Name
Email Address
Birth Date

Search Results

Now showing 1 - 5 of 5
  • PublicationMetadata only
    Serum Lityum Düzeyi Yüksek Olan Hastada Olası İlaçla İlgili Problemler: Bir Olgu Raporu
    (2021-06-17T00:00:00Z) Özmen, Özge; Sosyal, Damla; Bektay, Muhammed Yunus; Gürsoy, Azize Esra; İzzettin, Fikret Vehbi; ÖZMEN, ÖZGE; SOSYAL, DAMLA; BEKTAY, MUHAMMED YUNUS; GÜRSOY, AZIZE ESRA; İZZETTİN, FIKRET VEHBI
  • PublicationMetadata only
    Synthesis of Biologically Active Novel Sulfonamide Derivatives
    (2018-12-15) Çakmak, Elmas Begüm; Kahvecioğlu, Dilay; ZENGİN KURT, BELMA; SONMEZ, FATIH; ÖZMEN, ÖZGE; ZENGİN KURT, BELMA
  • PublicationMetadata only
    Treatment of coronavirus disease 2019: a comprehensive review
    (2020-11-01T00:00:00Z) Sosyal, Damla; Özmen, Özge; Bektay, Muhammed Yunus; İzzettin, Fikret Vehbi; SOSYAL, DAMLA; ÖZMEN, ÖZGE; BEKTAY, MUHAMMED YUNUS; İZZETTİN, FIKRET VEHBI
    The new type of Coronavirus (SARS-CoV-2) is a highly contagious pathogen that causes severe acute respiratory syndrome and can be transmitted from human to human. COVID-19, which has been declared as a pandemic by the world health organization and is infected with more than 50 million people, is also responsible for the death of more than 1 million people. There is no sufficient data from randomized clinical trials that any potential treatment improves outcomes in COVID-19 patients. Chloroquine and hydroxychloroquine, antivirals such as favipiravir, lopinavir/ritonavir, immunomodulatory agents tocilizumab, siltuximab, and sarilumab, and anti-inflammatory drugs such as steroids are used for the treatment of COVID-19. Repurposing drugs can provide new treatment options faster than discovering new drugs due to the known safety profiles of existing drugs. On the other hand, there are new drug and vaccine trials for COVID-19. Many researchers, governmental or non-governmental institutions having clinical trials for COVID-19 drugs and vaccines. In this comprehensive review, we investigate the clinical features, management, and treatment of COVID-19 and possible adverse effects and important information related to drugs used for COVID-19. For future preparedness and readiness, new laws and legislations should be constituted. Besides, emergency teams and budgets should be prepared as well.
  • PublicationMetadata only
    Identification of potentially inappropriate medications in elderly according to the FORTA and EU (7)-PIM lists: an observational study
    (2022-11-25) Özmen Ö.; Bektay M. Y.; Karatoprak C.; İzzettin F. V.; ÖZMEN, ÖZGE; BEKTAY, MUHAMMED YUNUS; KARATOPRAK, CUMALİ; İZZETTİN, FIKRET VEHBI
  • PublicationMetadata only
    Investigation of potential drug-drug interaction in chronic kidney disease patients in nephrology clinic
    (2021-12-01T00:00:00Z) Buker, Aysun; SOSYAL, Damla; ÖZMEN, ÖZGE; BEKTAY, MUHAMMED YUNUS; GÜRSU, Meltem; KAZANCIOĞLU, Rümeyza; İZZETTİN, Fikret Vehbi; SOSYAL, DAMLA; ÖZMEN, ÖZGE; BEKTAY, MUHAMMED YUNUS; GÜRSU, MELTEM; KAZANCIOĞLU, RÜMEYZA; İZZETTİN, FIKRET VEHBI